These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bullous systemic lupus erythematosus: An uncommon manifestation in pediatric population. Hasbún Z MT; Rollan MP; Chaparro R X; Fischer S C; Castrillón V A; González B S; Reculé F Andes Pediatr; 2021 Jun; 92(3):428-433. PubMed ID: 34479250 [TBL] [Abstract][Full Text] [Related]
4. Bullous systemic lupus erythematosus with lupus nephritis: a rare case of a subepidermal bullous disorder in a child. Poojary S; Rais S Cutis; 2012 Jan; 89(1):17-21. PubMed ID: 22439305 [TBL] [Abstract][Full Text] [Related]
5. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Contestable JJ; Edhegard KD; Meyerle JH Am J Clin Dermatol; 2014 Dec; 15(6):517-24. PubMed ID: 25358414 [TBL] [Abstract][Full Text] [Related]
6. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component. Chan LS; Cooper KD Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413 [TBL] [Abstract][Full Text] [Related]
8. Chronic bullous dermatosis of childhood. Tomecki KJ South Med J; 1983 May; 76(5):651-3. PubMed ID: 6342155 [TBL] [Abstract][Full Text] [Related]
9. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune bullous dermatoses: a review. Patrício P; Ferreira C; Gomes MM; Filipe P Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of bullous lupus with corticosteroids and belimumab: A case report. Keshavamurthy C; Fibeger E; Virata A; Bansal P Mod Rheumatol Case Rep; 2023 Jan; 7(1):52-56. PubMed ID: 35538618 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid. Nakahara Y; Yamane M; Sunada M; Aoyama Y J Dermatol; 2023 Feb; 50(2):162-165. PubMed ID: 36578130 [TBL] [Abstract][Full Text] [Related]
14. Utility of Direct Immunofluorescence Studies in Subclassification of Autoimmune Sub-Epidermal Bullous Diseases: A 2-Year Study in a Tertiary Care Hospital. Jain S; Basavaraj V; Vimala MG Turk Patoloji Derg; 2016; 32(2):91-8. PubMed ID: 27136107 [TBL] [Abstract][Full Text] [Related]
20. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time. Koga H; Ishii N; Hashimoto T; Nakama T J Dermatol; 2017 Feb; 44(2):189-193. PubMed ID: 28497856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]